Nuclear medicine review. Central & Eastern Europe最新文献

筛选
英文 中文
Increased physiological [18F]FDG uptake in the liver and blood pool among patients with impaired renal function. 肾功能受损患者肝脏和血池中FDG生理性摄取增加[18F]。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 Epub Date: 2022-07-18 DOI: 10.5603/NMR.a2022.0021
Yoichi Otomi, Yuta Arai, Maki Otomo, Saho Irahara, Kaori Terazawa, Michiko Kubo, Takashi Abe, Takayoshi Shinya, Hideki Otsuka, Masafumi Harada
{"title":"Increased physiological [18F]FDG uptake in the liver and blood pool among patients with impaired renal function.","authors":"Yoichi Otomi,&nbsp;Yuta Arai,&nbsp;Maki Otomo,&nbsp;Saho Irahara,&nbsp;Kaori Terazawa,&nbsp;Michiko Kubo,&nbsp;Takashi Abe,&nbsp;Takayoshi Shinya,&nbsp;Hideki Otsuka,&nbsp;Masafumi Harada","doi":"10.5603/NMR.a2022.0021","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0021","url":null,"abstract":"<p><strong>Background: </strong>In the daily clinical course, the liver uptake may seem to be increased in patients with renal failure. The purpose of this study was to investigate whether or not the FDG uptake of the liver, and the FDG uptake of blood pool which is generally used as a reference site as well as liver, is increased in patients with renal failure.</p><p><strong>Material and methods: </strong>We retrospectively analyzed 233 patients who underwent FDG positron emission tomography/computed tomography (PET/CT). Renal failure is defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2. We compared the FDG uptake in the liver and mediastinal blood pool of 67 patients with impaired renal function to that in 166 patients with a normal renal function (eGFR ≥ 60 mL/min/1.73 m2). Correlations between the liver or mediastinal blood pool FDG uptake and the eGFR were also analyzed by Spearman's correlation test.</p><p><strong>Results: </strong>Maximum and mean standardized uptake values (SUVmax and SUVmean, respectively) of the liver and the SUVmean of the mediastinal blood pool were 3.48 ± 0.57, 2.56 ± 0.37, and 1.90 ± 0.28 in the impaired renal function group, respectively, and 3.13 ± 0.45, 2.29 ± 0.33, and 1.66 ± 0.23, in the normal group, respectively. The SUVmax and SUVmean of the liver and SUVmean of the mediastinal blood pool in the impaired renal function group were significantly higher than those in the normal group (p < 0.001, < 0.001, and < 0.001, respectively). The SUVmax and SUVmean of the liver and SUVmean of the mediastinal blood pool of patients showed a significant negative correlation with the eGFR (Spearman's p = -0.25, -0.30, and -0.40, respectively, each p < 0.001).</p><p><strong>Conclusions: </strong>FDG uptake in both the liver and mediastinal blood pool was higher in patients with impaired renal function.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"95-100"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40515963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of [18F]FDG PET activity with expressions of Ki-67 in non-small-cell lung cancer. [18F]FDG PET活性与非小细胞肺癌中Ki-67表达的相关性
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0017
Ilknur Kucukosmanoglu, Meryem Ilkay Eren Karanis, Yasar Unlu, Mustafa Erol
{"title":"Correlation of [18F]FDG PET activity with expressions of Ki-67 in non-small-cell lung cancer.","authors":"Ilknur Kucukosmanoglu,&nbsp;Meryem Ilkay Eren Karanis,&nbsp;Yasar Unlu,&nbsp;Mustafa Erol","doi":"10.5603/NMR.a2022.0017","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0017","url":null,"abstract":"<p><strong>Background: </strong>Lung carcinoma is the most commonly diagnosed cancer throughout the world and is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for up to 80% of newly diagnosed lung cancer cases. This study aimed to investigate the relationship between Ki-67 proliferation index (PI) and the maximum standardized uptake value (SUVmax) obtained from [18F]FDG PET/CT in NSCLCs and whether prognosis was predicted with SUVmax values.</p><p><strong>Material and methods: </strong>This retrospective study included biopsy and resection materials of 41 patients, who were examined in the pathology laboratory of Konya Training and Research Hospital between January 2010 and December 2019, and diagnosed with NSCLC, and whose [18F]FDG PET/CT images were present.</p><p><strong>Results: </strong>There was no significant difference between histopathological subtypes in terms of age (p = 0.077), Ki-67 PI (p = 0.454), and SUVmax (p = 0.143). No correlation was observed between Ki-67 PI and SUVmax values obtained from [18F]FDG PET/CT (p = 0.338, r = 0.153). There was no significant correlation between Ki-67 PI and tumor diameter (p = 0.531). The SUVmax value was found to be lower (12.78 ± 6.14) in tumors measuring ≤ 2.5 in diameter and higher (18.46 ± 7.81) in tumors measuring > 2.5 cm (p = 0.027). Metastases not proven histopathologically but detected in [18F]FDG PET/CT were found to have no significant correlation with Ki-67 and SUVmax values (p = 0.881, p = 0.837).</p><p><strong>Conclusions: </strong>This study showed that there was no significant relationship between Ki-67 PI and SUVmax value obtained from [18F]FDG PET/CT in NSCLC tumors.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"73-77"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40335672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare osteoarticular complications on [18F]FDG-PET/CT - following intravesical BCG immunotherapy for bladder cancer. 膀胱内卡介苗免疫治疗膀胱癌后FDG-PET/CT少见的骨关节并发症[18F]
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0014
Jan-Henning Schierz, Anke McLeod, Farzana Ali
{"title":"Rare osteoarticular complications on [18F]FDG-PET/CT - following intravesical BCG immunotherapy for bladder cancer.","authors":"Jan-Henning Schierz,&nbsp;Anke McLeod,&nbsp;Farzana Ali","doi":"10.5603/NMR.a2022.0014","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0014","url":null,"abstract":"<p><p>This case illustrates rare osteoarticular complications of Bacillus Calmette-Guérin (BCG) immunotherapy in a 55-year-old male with high-risk non-muscle-invasive bladder cancer (NMIBC). The patient was referred for 18F-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) to rule out bone metastases suspected on prior post-gadolinium magnetic resonance imaging (MRI). Although metastases were excluded, nearly symmetrical uptakes were detected in the costovertebral and costotransverse joints. Medical history revealed that the patient had been receiving intravesical instillations of BCG, the first-line therapy for high-risk NMIBC. The patient was diagnosed with reactive arthritis (ReA), a rare autoimmune complication of BCG, that was successfully treated with a nonsteroidal anti-inflammatory drug (NSAID).</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"68-69"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39764938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal activity of [18F]FDG for Hodgkin lymphoma imaging performed on PET/CT camera with BGO crystals. [18F]FDG在带有BGO晶体的PET/CT相机上对霍奇金淋巴瘤成像的最佳活性。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0009
Miroslaw Dziuk, Ewa Witkowska-Patena, Agnieszka Gizewska, Andrzej Mazurek, Anna Pieczonka, Magdalena Koza, Marina Gerszewska, Zbigniew Podgajny, Marta Chojnowska
{"title":"Optimal activity of [18F]FDG for Hodgkin lymphoma imaging performed on PET/CT camera with BGO crystals.","authors":"Miroslaw Dziuk,&nbsp;Ewa Witkowska-Patena,&nbsp;Agnieszka Gizewska,&nbsp;Andrzej Mazurek,&nbsp;Anna Pieczonka,&nbsp;Magdalena Koza,&nbsp;Marina Gerszewska,&nbsp;Zbigniew Podgajny,&nbsp;Marta Chojnowska","doi":"10.5603/NMR.a2022.0009","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0009","url":null,"abstract":"<p><strong>Background: </strong>We aimed to find the minimum feasible activity of fluorodeoxyglucose ([18F]FDG) in positron emission tomography/computed tomography (PET/CT) of Hodgkin lymphoma patients performed on a camera with bismuth germanate (BGO) crystals.</p><p><strong>Material and methods: </strong>Ninety-one [18F]FDG PET/CT scans (each in seven Bayesian Penalized Likelihood [BPL] reconstructions with varying acquisition time per bed position - 2 min, 1.5 min, 1 min, 50 s, 40 s, 30 s, and 20 s) were independently assessed by three physicians to evaluate image quality. Mean administered activity was 3.0 ± 0.1 MBq/kg and mean uptake time was 54.0 ± 8.7 min. The series quality was subjectively marked on a 1-10 scale and then ranked 1-7 based on the mean mark. Interobserver rank correlation and intraclass correlation within each series for the three observers were calculated. Phantom studies were also performed to determine if reduced acquisition time can be directly translated into a reduced activity.</p><p><strong>Results: </strong>Time series were marked and ranked unanimously - the longer the time of acquisition the higher the mark and rank. The interobserver agreement in the ranking was excellent (100%) with a kappa coefficient of 1.00 (95% CI [0.83-1.0]). The general intraclass correlation coefficient (agreement between the marks observers gave each time series) was very high (0.945, 95% CI [0.936-0.952]) and was higher the shorter the time per bed. According to all three observers only the series with 2 min and 1.5 min acquisition time were appropriate for assessment (mean mark ≥ 7). In phantom studies there was a linear correlation between time per bed, administered activity, and number of total prompts detected by a scanner. Hence, a reduction of acquisition time of 25% (from 2 min to 1.5 min) could be directly translated into a 25% activity reduction (from 3.0 to 2.25 MBq/kg).</p><p><strong>Conclusions: </strong>In patients with HL, [18F]FDG activity can be reduced by up to 25% when using a BGO crystal camera, without substantial impact on image quality.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"47-53"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39902630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 4.000 € way to improve perceived quality and meet expectations of thyroid cancer patients receiving therapeutic dose of Iodine-131. 一个4000欧元的方式来提高感知质量和满足甲状腺癌患者接受治疗剂量碘-131的期望。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0031
Evanthia Giannoula, Christos Melidis, Nikitas Papadopoulos, Panagiotis Bamidis, Vasilios Raftopoulos, Vasiliki Chatzipavlidou, Ioannis Iakovou
{"title":"A 4.000 € way to improve perceived quality and meet expectations of thyroid cancer patients receiving therapeutic dose of Iodine-131.","authors":"Evanthia Giannoula,&nbsp;Christos Melidis,&nbsp;Nikitas Papadopoulos,&nbsp;Panagiotis Bamidis,&nbsp;Vasilios Raftopoulos,&nbsp;Vasiliki Chatzipavlidou,&nbsp;Ioannis Iakovou","doi":"10.5603/NMR.a2022.0031","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0031","url":null,"abstract":"<p><strong>Background: </strong>Thyroid cancer is the most common malignant disease of the endocrine system and radioiodine therapy (RAIT) is still very often used, resulting in patients staying hospitalized for a few days alone and without visitors, augmenting their stress and discomfort. Our objective was to find simple ways of improving RAIT patients' feelings and perceived quality of the nuclear medicine (NM) department services.</p><p><strong>Material and methods: </strong>We designed a two-year study in order to enhance RAIT patients' perceived quality of the nuclear medicine (NM) department services and expectations' fulfillment. A questionnaire was used in order to capture patients' perceived quality and expectations from their RAIT.</p><p><strong>Results: </strong>549 replies were collected. Many intrinsic and extrinsic determinants were found to be positively or negatively related to the perceived quality and fulfillment of patients' expectations of receiving RAIT. A 1% increase could be achieved by spending 110 € per RAIT room.</p><p><strong>Conclusions: </strong>In this article, we present some easily implemented changes in both personnel behavior and room amenities that could, at least in theory and based on our results, offer a 37.9% improvement in RAIT patients' perceived quality and expectations' fulfillment at a cost of 4169 €.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"138-140"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40335673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amino acid extravasation: a rare red flag to keep in mind during peptide receptor radioligand therapy (PRRT) with [177Lu]Lu-DOTATATE. 氨基酸外溢:使用[177Lu]Lu-DOTATATE进行肽受体放射配体治疗(PRRT)时需要注意的罕见危险信号。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 Epub Date: 2022-07-18 DOI: 10.5603/NMR.a2022.0030
Ghasemali Divband, Seyed Hootan Alavi, Zohre Adinehpour, Forough Kalantari, Soroush Zarehparvar Moghadam
{"title":"Amino acid extravasation: a rare red flag to keep in mind during peptide receptor radioligand therapy (PRRT) with [177Lu]Lu-DOTATATE.","authors":"Ghasemali Divband,&nbsp;Seyed Hootan Alavi,&nbsp;Zohre Adinehpour,&nbsp;Forough Kalantari,&nbsp;Soroush Zarehparvar Moghadam","doi":"10.5603/NMR.a2022.0030","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0030","url":null,"abstract":"<p><p>A 64 years-old woman with intestinal neuroendocrine tumor (NET) and multiple liver metastases was referred for peptide receptor radioligand therapy (PRRT) with [177Lu]Lu-DOTATATE. A few days after the third cycle of PRRT, erythema and swelling in the injection site is occurred which progressed up to one-month post-therapy. The cutaneous lesion was managed by a plastic surgeon with topical treatment. Amino acid extravasation could have devastating effects and should always be considered in patients who underwent PRRT and who receive amino acids for nephroprotection.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"136-137"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40603833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Preoperative detection of sentinel lymph node in patients with endometrial cancer - comparison of planar lymphoscintigraphy, spect and SPECT/CT. 子宫内膜癌患者前哨淋巴结的术前检查——平面淋巴显像、spect和spect /CT的比较。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0022
Anamarija Jankulovska, Bojana Stoilovska Rizova, Nikolina Bozhinovska, Aleksandra Peshevska, Mile Tanturovski, Igor Aluloski, Sasho Stojcevski, Nevena Manevska, Sinisa Stojanoski, Daniela Miladinova
{"title":"Preoperative detection of sentinel lymph node in patients with endometrial cancer - comparison of planar lymphoscintigraphy, spect and SPECT/CT.","authors":"Anamarija Jankulovska,&nbsp;Bojana Stoilovska Rizova,&nbsp;Nikolina Bozhinovska,&nbsp;Aleksandra Peshevska,&nbsp;Mile Tanturovski,&nbsp;Igor Aluloski,&nbsp;Sasho Stojcevski,&nbsp;Nevena Manevska,&nbsp;Sinisa Stojanoski,&nbsp;Daniela Miladinova","doi":"10.5603/NMR.a2022.0022","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0022","url":null,"abstract":"<p><strong>Background: </strong>Sentinel lymph node (SLN) mapping allows minimal invasive assessment of lymph node status in patients with early-stage endometrial cancer (EC). Intraoperative detection of SLNs is based on the results obtained from preoperative nuclear medical images. The purpose of this study was to compare the data obtained from planar lymphoscintigraphy (PL), single-photon emission computed tomography (SPECT), and SPECT with computed tomography (SPECT/CT) for preoperative SLN detection in patients with EC.</p><p><strong>Material and methods: </strong>A total of 44 images in 22 patients with early-stage EC (22 PL, 9 SPECT and 13 SPECT/CT) were analyzed. The scans were performed in the period 2018-2020 at the Institute of Pathophysiology and Nuclear Medicine in Skopje. Thirteen patients underwent PL and SPECT/CT and nine patients underwent PL and SPECT after cervical injection of 4 mCi 99mTc-SENTI-SCINT on the day of surgery. Descriptive statistics, Wilcoxon Matched Pairs Test, and Spearman rank R coefficient were used for data analyses.</p><p><strong>Results: </strong>Twenty-two patients with mean age of 61.1 ± 7.5 and body mass index (BMI) 34.62 ± 6.4 kg/m2 were included in the study. In four patients (18.2%) SLN was not detected on PL. Detection rate on SPECT and SPECT/CT was 100%. The average number of detected SLN was 1.4 ± 1.05, 2.2 ± 1.1 и 2.15 ± 1.1 on PL, SPECT and SPECT/CT respectively. We found a statistically significant difference in the number of detected SLNs on PL vs SPECT/CT (p = 0.0077). The most common SLN location on SPECT/CT was the right internal iliac followed by the left common iliac region.</p><p><strong>Conclusions: </strong>The results of the presented study indicate a higher diagnostic value of SPECT/CT in terms of SLN detection and exact anatomic localization as compared to planar lymphoscintigraphy (PL).</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"101-104"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40672307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocardial perfusion imaging using single-photon emission computed tomography with cadmium-zinc-telluride technology. 采用碲化镉锌技术的单光子发射计算机断层扫描心肌灌注成像。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 Epub Date: 2022-07-18 DOI: 10.5603/NMR.a2022.0025
Sonia J Konsek-Komorowska, Mariola Peczkowska, Jaroslaw B Cwikła
{"title":"Myocardial perfusion imaging using single-photon emission computed tomography with cadmium-zinc-telluride technology.","authors":"Sonia J Konsek-Komorowska,&nbsp;Mariola Peczkowska,&nbsp;Jaroslaw B Cwikła","doi":"10.5603/NMR.a2022.0025","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0025","url":null,"abstract":"<p><p>Myocardial perfusion imaging (MPI) with single-photon emission computed tomography (SPECT) is a well-established diagnostic approach for patients with suspected or confirmed coronary artery disease (CAD). In the present century, nuclear cardiology has benefited immensely from advances in imaging instrumentation and technology. Dedicated cardiac SPECT cameras incorporating novel, highly efficient cadmium-zinc-telluride (CZT) detectors, collimators, and system designs have evolved as a result of the expansion of nuclear cardiology. A vast amount of evidence is emerging, demonstrating the new technology's advantages over the traditional gamma cameras. Myocardial perfusion imaging (MPI) using gamma-cameras with CZT detectors may be performed with the limited injected activity of radiotracer and recorded times. The use of CZT's dynamic acquisition of myocardial perfusion imaging in clinical practice may help cardiologists in detecting hemodynamically significant CAD. In this article, we present the current state of knowledge on cardiac CZT-SPECT scanners, a summary of the literature published on validation studies, radiation dose reduction, and dynamic acquisition, as well as a comparison of conventional myocardial perfusion imaging with invasive coronary angiography.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"119-126"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40625853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple benefits of added computed tomography for myocardial perfusion imaging in patients with psoriasis. 银屑病患者心肌灌注显像增加计算机断层扫描的多重益处。
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0032
Joseph C Lee, Alaa Alghamry
{"title":"Multiple benefits of added computed tomography for myocardial perfusion imaging in patients with psoriasis.","authors":"Joseph C Lee,&nbsp;Alaa Alghamry","doi":"10.5603/NMR.a2022.0032","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0032","url":null,"abstract":"","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"141"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40695822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset Lewy body disease. 新发路易体病脑血流减少模式与非运动症状的关系
IF 0.9
Nuclear medicine review. Central & Eastern Europe Pub Date : 2022-01-01 DOI: 10.5603/NMR.a2022.0005
Yukinori Okada, Makoto Shiraishi, Koji Hori, Keiichro Yamaguchi, Yasuhiro Hasegawa
{"title":"Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset Lewy body disease.","authors":"Yukinori Okada,&nbsp;Makoto Shiraishi,&nbsp;Koji Hori,&nbsp;Keiichro Yamaguchi,&nbsp;Yasuhiro Hasegawa","doi":"10.5603/NMR.a2022.0005","DOIUrl":"https://doi.org/10.5603/NMR.a2022.0005","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the relationship between patterns of reduced cerebral blood flow (CBF) evaluated by means of 123I-N-isopropyl-p-iodoamphetamine ([123I]IMP) scintigraphy and nonmotor symptoms in new-onset Lewy body disease (Parkinson's disease and dementia with Lewy bodies [DLB]).</p><p><strong>Material and methods: </strong>Twenty-four patients diagnosed with new-onset Parkinson's disease or DLB underwent [123I]IMP CBF scintigraphy at St. Marianna Medical University Hospital between January 1, 2010, and March 30, 2018. The reductions in CBF in various brain regions were analyzed using the three-dimensional stereotactic surface projection method and were compared to standard database values, yielding extent values (%). The extent values were evaluated in relation to the presence/absence of motor or nonmotor symptoms such as visual hallucinations, auditory hallucinations, delirium, depression, delusions, and dementia.</p><p><strong>Results: </strong>The extent value was 100% in the angular, supramarginal, and lingual gyri; 95% in the orbital gyri; and 92.6% in the fusiform gyri. The extent value in patients without hallucinations and those with visual hallucinations was 41.2% and 54.3%, respectively, in the frontal lobe (p = 0.02) and 33.3% and 51.0%, respectively, in the medial prefrontal gyri (p = 0.02). Age-adjusted multivariate analysis showed that extent values in the frontal lobe were associated with visual hallucinations (odds ratio: 1.09, 95% confidence interval 1.00-1.18, p = 0.04).</p><p><strong>Conclusions: </strong>The above results show that the CBF is reduced in several areas of the cerebral cortex and suggest an association between reduced blood flow in the frontal lobe and the appearance of visual hallucinations in patients with new-onset DLB.</p>","PeriodicalId":520725,"journal":{"name":"Nuclear medicine review. Central & Eastern Europe","volume":" ","pages":"18-24"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39902625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信